Poseida: Poseida Nominates New Development Candidate Under Its Collaboration with Roche
The new candidate is an allogeneic, dual CAR-T therapy targeting known antigens expressed in hematologic malignancies.
Read full article »
Poseida is a California-based biopharmaceutical company that researches and develops gene therapies for the treatment of cancer and genetic diseases.
Read more